Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2001 9
2002 9
2003 11
2004 11
2005 12
2006 13
2007 6
2008 6
2009 2
2010 3
2011 5
2012 1
2013 1
2015 1
2017 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 16763490

91 results

Results by year

Filters applied: . Clear all
Page 1
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM. Staszewski S, et al. N Engl J Med. 1999 Dec 16;341(25):1865-73. doi: 10.1056/NEJM199912163412501. N Engl J Med. 1999. PMID: 10601505 Free article. Clinical Trial.
Efficacy and safety of a quadruple combination Combivir + abacavir + efavirenz regimen in antiretroviral treatment-naive HIV-1-infected adults: La Francilienne.
de Truchis P, Force G, Welker Y, Mechali D, Pulik M, Chemlal K, Rouveix E, Devidas A, Praindhui D, Mamet JP; CNAF3008 Group. de Truchis P, et al. J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):178-82. doi: 10.1097/00126334-200210010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 12394796 Clinical Trial.
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouédraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouédraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timité-Konan M, Leroy V; MONOD Study Group. Dahourou DL, et al. BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4. BMC Med. 2017. PMID: 28434406 Free PMC article. Clinical Trial.
91 results